Platelets and cardiac arrhythmia

Frontiers in Physiology

Volumn 1 DEC, Issue , 2010, Pages

  de Jong, Jonas S S G ^a   Dekker, Lukas R C ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Arrhythmias; Cardiac; Platelets; Sudden death; Ventricular fibrillation

Indexed keywords

EID: 84866415106     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2010.00166     Document Type: Review

References (95)

1. Ahn, Y. K., Cho, J. G., Park, W. S., Kim, N. H., Kim, J. W., Kim, S. H., Cho, J. H., Park, J. H., Jeong, M. H., Park, J. C., and Kang, J. C. (1999). The effects of antiplatelet agents in the prevention of ventricular tachyarrhythmias during acute myocardial ischemia in rats. Jpn. Heart J. 40, 79-86.
2. Akar, J. G., and Akar, F. G. (2007). Regulation of ion channels and arrhythmias in the ischemic heart. J. Electrocardiol. 40, S37-S41.
3. Al-Sayegh, A., Shukkur, A. M., and Akbar, M. (2007). Automatic implantable cardioverter defibrillator for the treatment of ventricular fibrillation following coronary artery spasm: a case report. Angiology 58, 122-125.
4. Alloatti, G., Montrucchio, G., and Camussi, G. (1990). Prostacyclin inhibits the platelet-dependent effects of plateletactivating factor in the rabbit isolated heart. J. Cardiovasc. Pharmacol. 15, 745-751.
5. Ashton, J. H., Benedict, C. R., Fitzgerald, C., Raheja, S., Taylor, A., Campbell, W. B., Buja, L. M., and Willerson, J. T. (1986). Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 73, 572-578.
6. Bach, T., Syversveen, T., Kvingedal, A. M., Krobert, K. A., Brattelid, T., Kaumann, A. J., and Levy, F. O. (2001). 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn-Schmiedeberg's Arch. Pharmacol. 363, 146-160.
7. Barta, J., Sanganalmath, S. K., Kumamoto, H., Takeda, N., Edes, I., and Dhalla, N. S. (2008). Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc. Toxicol. 8, 127-135.
8. Born, G. V., and Kratzer, M. A. (1984). Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J. Physiol. 354, 419-429.
9. Brattelid, T., Qvigstad, E., Lynham, J. A., Molenaar, P., Aass, H., Geiran, O., Skomedal, T., Osnes, J.-B., Levy, F. O., and Kaumann, A. J. (2004). Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure. Naunyn-Schmiedeberg's Arch. Pharmacol. 370, 157-166.
10. Carmeliet, E. (1999). Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev. 79, 917-1017.
11. Chen, B., Cheng, Q., Yang, K., and Lyden, P. D. (2010). Thrombin mediates severe neurovascular injury during ischemia. Stroke 41, 2348-2352.
12. Chen, J., Capdevila, J. H., Zeldin, D. C., and Rosenberg, R. L. (1999). Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol. Pharmacol. 55, 288-295.
13. Chien, W. W., Mohabir, R., Newman, D., Leung, L. L., and Clusin, W. T. (1990). Effect of platelet release products on cytosolic calcium in cardiac myocytes. Biochem. Biophys. Res. Commun. 170, 1121-1127.
14. Christie, A., Sharma, V. K., and Sheu, S. S. (1992). Mechanism of extracellular ATP-induced increase of cytosolic Ca2+ concentration in isolated rat ventricular myocytes. J. Physiol. 445, 369-388.
15. Chugh, S. S., Reinier, K., Teodorescu, C., Evanado, A., Kehr, E., Al Samara, M., Mariani, R., Gunson, K., and Jui, J. (2008). Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. 51, 213-228.
16. Clerck, F., Nueten, J. M., and Reneman, R. S. (1984). Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review. Agents Actions 15, 612-626.
17. Coade, S. B., and Pearson, J. D. (1989). Metabolism of adenine nucleotides in human blood. Circ. Res. 65, 531-537.
18. Coppinger, J. A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., McRedmond, J. P., Cahill, D. J., Emili, A., Fitzgerald, D. J., and Maguire, P. B. (2004). Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104.
19. Coronel, R., Fiolet, J. W., WilmsSchopman, F. J., Schaapherder, A. F., Johnson, T. A., Gettes, L. S., and Janse, M. J. (1988). Distribution of extracellular potassium and its relation to electrophysiologic changes during acute myocardial ischemia in the isolated perfused porcine heart. Circulation 77, 1125-1138.
20. Coronel, R., Wilms-Schopman, F. J., and Janse, M. J. (1997). Profibrillatory effects of intracoronary thrombus in acute regional ischemia of the in situ porcine heart. Circulation 96, 3985-3991.
21. Coronel, R., Wilms-Schopman, F. J., Opthof, T., van Capelle, F. J., and Janse, M. J. (1991). Injury current and gradients of diastolic stimulation threshold, TQ potential, and extracellular potassium concentration during acute regional ischemia in the isolated perfused pig heart. Circ. Res. 68, 1241-1249.
22. da Silva, C. G., Specht, A., Wegiel, B., Ferran, C., and Kaczmarek, E. (2009). Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 119, 871-879.
23. Danziger, R. S., Raffaeli, S., MorenoSanchez, R., Sakai, M., Capogrossi, M. C., Spurgeon, H. A., Hansford, R. G., and Lakatta, E. G. (1988). Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes. Cell Calcium 9, 193-199.
24. Dauber, I. M., VanBenthuysen, K. M., McMurtry, I. F., Wheeler, G. S., Lesnefsky, E. J., Horwitz, L. D., and Weil, J. V. (1990). Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ. Res. 66, 986-998.
25. Davies, M. J., and Thomas, A. (1984). Thrombosis and acute coronaryartery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310, 1137-1140.
26. De Clerck, F. (1986). Blood platelets in human essential hypertension. Agents Actions 18, 563-580.
27. De Clerck, F., Xhonneux, B., Leysen, J., and Janssen, A. P. (1984). Evidence for functional 5-HT2 receptor sites on human blood platelets. Biochem. Pharmacol. 33, 2807-2811.
28. Dekker, L. R., Fiolet, J. W., VanBavel, E., Coronel, R., Opthof, T., Spaan, J. A., and Janse, M. J. (1996). Intracellular Ca2+, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ. Res. 79, 237-246.
29. Diercks, D. B., Shumaik, G. M., Harrigan, R. A., Brady, W. J., and Chan, T. C. (2004). Electrocardiographic manifestations: electrolyte abnormalities. J. Emerg. Med. 27, 153-160.
30. Edmunds, N. J., Lal, H., and Woodward, B. (1999). Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function. Br. J. Pharmacol. 126, 189-196.
31. Filep, J. G., Földes-Filep, E., and Sirois, P. (1993). Nitric oxide modulates vascular permeability in the rat coronary circulation. Br. J. Pharmacol. 108, 323-326.
32. Flores, N. A., Botchway, A. N., Stavrou, B. M., and Sheridan, D. J. (1999). Cardiac electrophysiological effects of plateletderived substances. Exp. Physiol. 84, 253-274.
33. Flores, N. A., and Sheridan, D. J. (1990). Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Br. J. Pharmacol. 101, 734-738.
34. Frink, R. J., Rooney, P. A., Trowbridge, J. O., and Rose, J. P. (1988). Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br. Heart J. 59, 196-200.
35. Ginsburg, R., Bristow, M. R., Stinson, E. B., and Harrison, D. C. (1980). Histamine receptors in the human heart. Life Sci. 26, 2245-2249.
36. Greer, J. P. (2008). Wintrobe's Clinical Hematology. Philadelphia: Lippincott Williams and Wilkins.
37. Gresele, P., Page, C. P., and Vermylen, J. (2002). Platelets in Thrombotic and Nonthrombotic Disorders. Cambridge, UK: Cambridge University Press.
38. Gurung, I. S., Kalin, A., Grace, A. A., and Huang, C. L.-H. (2009). Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis. J. Mol. Cell. Cardiol. 47, 622-633.
39. Hendriks, M. L., Allaart, C. P., Bronzwaer, J. G. F., Res, J. J. C., and de Cock, C. C. (2008). Recurrent ventricular fibrillation caused by coronary artery spasm leading to implantable cardioverter defibrillator implantation. Europace 10, 1456-1457.
40. Hoffman, B. F., Feinmark, S. J., and Guo, S. D. (1997). Electrophysiologic effects of interactions between activated canine neutrophils and cardiac myocytes. J. Cardiovasc. Electrophysiol. 8, 679-687.
41. Hoffman, B. F., Guo, S. D., and Feinmark, S. J. (1996). Arrhythmias caused by platelet activating factor. J. Cardiovasc. Electrophysiol. 7, 120-133.
42. Hoffmann, P., Heinroth-Hoffmann, I., and Toraason, M. (1993). Alterations by a thromboxane A2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes. J. Pharmacol. Exp. Ther. 264, 336-344.
43. Holmsen, H., and Weiss, H. J. (1979). Secretable storage pools in platelets. Annu. Rev. Med. 30, 119-134.
44. Hung, M.-J., Cheng, C.-W., Yang, N.-I., Hung, M.-Y., and Cherng, W.-J. (2007). Coronary vasospasminduced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease. Int. J. Cardiol. 117, 37-44.
45. Jancinová, V., and Nosál, R. (1998). Increased histamine content in Ca2+-ionophore A23187-activated human blood platelets. Platelets 9, 203-206.
46. Johnson, G. J., Heckel, R., Leis, L. A., and Franciosa, J. (1981). Effect of inhibition of platelet function with carbenicillin or aspirin on experimental canine sudden death. J. Lab. Clin. Med. 98, 660-672.
47. Jones, S., Tucker, K. L., Sage, T., Kaiser, W. J., Barrett, N. E., Lowry, P. J., Zimmer, A., Hunt, S. P., Emerson, M., and Gibbins, J. M. (2008). Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood 111, 605-612.
48. Kaski, J. C., Crea, F., Meran, D., Rodriguez, L., Araujo, L., Chierchia, S., Davies, G., and Maseri, A. (1986). Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 74, 1255-1265.
49. Kaumann, A. J. (1994). Do human atrial 5-HT4 receptors mediate arrhythmias? Trends Pharmacol. Sci. 15, 451-455.
50. Kaumann, A. J., and Levy, F. O. (2006). 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol. Ther. 111, 674-706.
51. Kaumann, A. J., Sanders, L., Brown, A. M., Murray, K. J., and Brown, M. J. (1990). A 5-hydroxytryptamine receptor in human atrium. Br. J. Pharmacol. 100, 879-885.
52. Kléber, A. G., Riegger, C. B., and Janse, M. J. (1987). Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ. Res. 61, 271-279.
53. Larsson, L., and Ohman, S. (1978). Serum ionized calcium and corrected total calcium in borderline hyperparathyroidism. Clin. Chem. 24, 1962-1965.
54. Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., and Chalmers, T. C. (1992). Cumulative meta-analysis of therapeutic trials for myocardial infarction. N. Engl. J. Med. 327, 248-254.
55. Lee, H. C., Lu, T., Weintraub, N. L., VanRollins, M., Spector, A. A., and Shibata, E. F. (1999). Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J. Physiol. 519(PART 1), 153-168.
56. Lown, B., and Wolf, M. (1971). Approaches to sudden death from coronary heart disease. Circulation 44, 130-142.
57. Maguire, P. B., and Fitzgerald, D. J. (2003). Platelet proteomics. J. Thromb. Haemost. 1, 1593-1601.
58. Maguire, P. B., Wynne, K. J., Harney, D. F., O'Donoghue, N. M., Stephens, G., and Fitzgerald, D. J. (2002). Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2, 642-648.
59. Massey, K. D., Minnich, B. N., and Burt, J. M. (1992). Arachidonic acid and lipoxygenase metabolites uncouple neonatal rat cardiac myocyte pairs. Am. J. Physiol. 263, C494-C501.
60. McFadden, E. P., Clarke, J. G., Davies, G. J., Kaski, J. C., Haider, A. W., and Maseri, A. (1991). Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N. Engl. J. Med. 324, 648-654.
61. McNicol, A., and Israels, S. J. (1999). Platelet dense granules: structure, function and implications for haemostasis. Thromb. Res. 95, 1-18.
62. McRedmond, J. P., Park, S. D., Reilly, D. F., Coppinger, J. A., Maguire, P. B., Shields, D. C., and Fitzgerald, D. J. (2004). Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol. Cell. Proteomics 3, 133-144.
63. Mei, Q., and Liang, B. T. (2001). P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 281, H334-H341.
64. Meyers, K. M., Holmsen, H., and Seachord, C. L. (1982). Comparative study of platelet dense granule constituents. Am. J. Physiol. 243, R454-R461.
65. Moffat, M. P., Ward, C. A., Bend, J. R., Mock, T., Farhangkhoee, P., and Karmazyn, M. (1993). Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am. J. Physiol. 264, H1154-H1160.
66. Moschos, C. B., Haider, B., De La Cruz, C., Lyons, M. M., and Regan, T. J. (1978). Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion. Circulation 57, 681-684.
67. Ouadid, H., Seguin, J., Dumuis, A., Bockaert, J., and Nargeot, J. (1992). Serotonin increases calcium current in human atrial myocytes via the newly described 5hydroxytryptamine4 receptors. Mol. Pharmacol. 41, 346-351.
68. Pau, D., Workman, A. J., Kane, K. A., and Rankin, A. C. (2003). Electrophysiological effects of 5hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br. J. Pharmacol. 140, 1434-1441.
69. Pucéat, M., Clément, O., Scamps, F., and Vassort, G. (1991). Extracellular ATPinduced acidification leads to cytosolic calcium transient rise in single rat cardiac myocytes. Biochem. J. 274(PART 1), 55-62.
70. Ralevic, V., and Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
71. Ramírez, M. M., Quardt, S. M., Kim, D., Oshiro, H., Minnicozzi, M., and Durán, W. N. (1995). Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc. Res. 50, 223-234.
72. Rendu, F., and Brohard-Bohn, B. (2001). The platelet release reaction: granules' constituents, secretion and functions. Platelets 12, 261-273.
73. Saito, T., Sato, T., Miki, T., Seino, S., and Nakaya, H. (2005). Role of ATP-sensitive K+ channels in electrophysiological alterations during myocardial ischemia: a study using Kir6.2-null mice. Am. J. Physiol. Heart Circ. Physiol. 288, H352-H357.
74. Sanna, T., Lanza, G. A., Niccoli, G., La Torre, G., Cosentino, N., and Crea, F. (2009). Coronary artery vasospasm causing ventricular fibrillation - an external loop recording. Resuscitation 80, 393-394.
75. Sansone, F., Trichiolo, S., Ceresa, F., Attisani, M., Berardo, A., and Rinaldi, M. (2009). Recurrent ventricular fibrillation due to coronary artery spasm immediately after ascending aorta replacement. J. Cardiovasc. Med. (Hagerstown) 10, 810-812.
76. Sauer, W. H., Berlin, J. A., and Kimmel, S. E. (2003). Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108, 32-36.
77. Scamps, F., and Vassort, G. (1990). Mechanism of extracellular ATPinduced depolarization in rat isolated ventricular cardiomyocytes. Pflugers Arch. 417, 309-316.
78. Seniuk, W., Mularek-Kubzdela, T., Grygier, M., Grajek, S., and Cieś liński, A. (2002). Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study. J. Intern. Med. 252, 368-376.
79. Shah, A. M., Meulemans, A. L., and Brutsaert, D. L. (1989). Myocardial inotropic responses to aggregating platelets and modulation by the endocardium. Circulation 79, 1315-1323.
80. Shehadeh, A. A., Arena, J., Moschos, C. B., and Regan, T. J. (2000). Nonplatelet effects of aspirin during acute coronary occlusion: electrophysiologic and cation alterations in ischemic myocardium. J. Cardiovasc. Pharmacol. Ther. 5, 113-120.
81. Solomon, S. D., Ridker, P. M., and Antman, E. M. (1993). Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis. Circulation 88, 2575-2581.
82. Sunnergren, K. P., and Rovetto, M. J. (1980). Microvascular permeability characteristics of the isolated perfused ischemic rat heart. J. Mol. Cell. Cardiol. 12, 1011-1031.
83. Sunnergren, K. P., and Rovetto, M. J. (1987). Myocyte and endothelial injury with ischemia reperfusion in isolated rat hearts. Am. J. Physiol. Heart Circ. Physiol. 252, H1211-H1217.
84. Tabrizchi, R. (2001). The influence of tumour necrosis factor-alpha on the cardiovascular system of anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 363, 307-321.
85. Ter Keurs, H. E., and Boyden, P. A. (2007). Calcium and arrhythmogenesis. Physiol. Rev. 87, 457-506.
86. Tompkins, J. D., Hoover, D. B., and Hancock, J. C. (1999). Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons. Peptides 20, 623-628.
87. Trip, M. D, Cats, V. M., van Capelle, F. J., and Vreeken, J. (1990). Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 322, 1549-1554.
88. Verkerk, A. O., Veldkamp, M. W., Bouman, L. N., and van Ginneken, A. C. (2000). Calcium-activated Cl(-) current contributes to delayed after depolarizations in single Purkinje and ventricular myocytes. Circulation 101, 2639-2644.
89. Vikenes, K., Farstad, M., and Nordrehaug, J. E. (1999). Serotonin is associated with coronary artery disease and cardiac events. Circulation 100, 483-489.
90. Wacker, M. J., Kosloski, L. M., Gilbert, W. J. R., Touchberry, C. D., Moore, D. S., Kelly, J. K., Brotto, M., and Orr, J. A. (2009). Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway. J. Pharmacol. Exp. Ther. 331, 917-924.
91. Wainwright, C. L., Parratt, J. R., and Bigaud, M. (1989). The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. Eur. Heart J. 10, 235-243.
92. Wilde, A. A., Escande, D., Schumacher, C. A., Thuringer, D., Mestre, M., Fiolet, J. W., and Janse, M. J. (1990). Potassium accumulation in the globally ischemic mammalian heart. A role for the ATPsensitive potassium channel. Circ. Res. 67, 835-843.
93. Wolff, A. A., and Levi, R. (1986). Histamine and cardiac arrhythmias. Circ. Res. 58, 1-16.
94. Xiao, Y.-F. (2007). Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids. Prostaglandins Other Lipid Mediat. 82, 11-18.
95. Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C., Jr., Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J. J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., and Zamorano, J. L. (2006). ACC/AHA/ ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J. Am. Coll. Cardiol. 48, e247-e346.